Non-Optimized Medication Therapy Costs U.S. $528.4 Billion Annually, Study Finds

April 13, 2018

Non-optimized medications, including medication nonadherence, cost the U.S. $528.4 billion in 2016 due to morbidity and mortality, according to a study published March 26 in the Annals of Pharmacotherapy.

The cost is equivalent to 16 percent of total U.S. healthcare expenditures in 2016.

The study, “Cost of Prescription Drug-Related Morbidity and Mortality,” considered that public attention has focused on prescription drug prices. But the authors sought to look at the cost of prescription drugs beyond the purchasing costs.

“We propose expansion of comprehensive medication management programs by clinical pharmacists in collaborative practices with physicians and other prescribers as an effective and scalable approach to mitigate these avoidable costs and improve patient outcomes,” according to the study’s authors.

View the study.